Franklin

Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.

Author/Creator:
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author.
Other Title:
Antitrust concerns and the Food and Drug Administration approval process
Publication:
Washington : U.S. Government Publishing Office, 2018.
Format/Description:
Government document
Book
1 online resource (iv, 51 pages)
Subjects:
United States. Food and Drug Administration -- Rules and practice.
Drugs -- United States -- Testing.
Drug approval -- United States.
Drugs -- Safety regulations -- United States.
Medical instruments and apparatus -- Safety regulations -- United States.
Generic drugs -- United States.
Competition -- United States.
Antitrust law -- United States.
United States. Food and Drug Administration.
Antitrust law.
Competition.
Drug approval.
Drugs -- Safety regulations.
Drugs -- Testing.
Generic drugs.
Medical instruments and apparatus -- Safety regulations.
United States.
Form/Genre:
Legislative hearings.
Rules.
Legislative hearings.
Notes:
Online resource; title from PDF title screens (govinfo web site, viewed on June 27, 2018).
"Serial no. 115-27."
CRDP Program record.
Other format:
Print version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process
Microfiche version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process
OCLC:
1042073861
Loading...
Location Notes Your Loan Policy
Description Status Barcode Your Loan Policy